Patents Assigned to Boehringr Ingelheim International GmbH
  • Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
    Patent number: 10195203
    Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: February 5, 2019
    Assignee: Boehringr Ingelheim International GmbH
    Inventors: Thomas Klein, Maximilian von Eynatten, Michael Mark